J
Jonathan Cohen
Researcher at Hebrew University of Jerusalem
Publications - 146
Citations - 6260
Jonathan Cohen is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 30, co-authored 121 publications receiving 5247 citations. Previous affiliations of Jonathan Cohen include Royal North Shore Hospital & Flinders University.
Papers
More filters
Journal ArticleDOI
A Review of School Climate Research
TL;DR: This paper presented an integrative review on school climate research, focusing on five essential dimensions of school climate: Safety, Relationships, Teaching and Learning, Institutional Environment, and the School Improvement Process.
Journal ArticleDOI
School Climate: Research, Policy, Practice, and Teacher Education
TL;DR: A sustainable, positive school climate fosters youth development and learning necessary for a productive, contributive, and satisfying life in a democratic society as mentioned in this paper, including norms, goals, values, interpersonal relationships, teaching and learning practices, and organizational structures.
Journal ArticleDOI
Social, Emotional, Ethical, and Academic Education: Creating a Climate for Learning, Participation in Democracy, and Well-Being.
TL;DR: Cohen argues that the goals of education need to be reframed to prioritize not only academic learning, but also social, emotional, and ethical competencies as mentioned in this paper, and advocates for action research partnerships between researchers and practioners to develop authentic methods of evaluation.
Journal ArticleDOI
MicroRNA regulation of homeostatic synaptic plasticity.
TL;DR: A role is revealed for this previously uncharacterized miRNA and the presynaptic protein SV2A in homeostatic plasticity and nervous system development, with possible implications in neurological disorders (e.g., Huntington and Alzheimer's disease), where miR-485 has been found to be dysregulated.
Journal ArticleDOI
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N. Amaria,Alexander M. Menzies,Alexander M. Menzies,Alexander M. Menzies,Elizabeth M. Burton,Richard A. Scolyer,Richard A. Scolyer,Michael T. Tetzlaff,Robert Antdbacka,Charlotte E. Ariyan,Roland L. Bassett,Brett W. Carter,Adil Daud,Mark B. Faries,Leslie A. Fecher,Keith T. Flaherty,Jeffrey E. Gershenwald,Omid Hamid,Angela Hong,Angela Hong,John M. Kirkwood,Serigne Lo,Kim Margolin,Jane L. Messina,Michael A. Postow,Michael A. Postow,Helen Rizos,Helen Rizos,Merrick I. Ross,Elisa A. Rozeman,Robyn P. M. Saw,Robyn P. M. Saw,Robyn P. M. Saw,Vernon K. Sondak,Ryan J. Sullivan,Janis M. Taube,John F. Thompson,John F. Thompson,John F. Thompson,Bart A. van de Wiel,Alexander M.M. Eggermont,Michael A. Davies,Miles C. Andrews,Donald A. Berry,Matthew S. Block,Genevieve M. Boland,Kathryn Bollin,Matteo S. Carlino,Richard D. Carvajal,Jonathan Cohen,Diwakar Davar,Keith A. Delman,Reinhard Dummer,Michael D. Farwell,David E. Fisher,Alberto Fusi,Isabella C. Glitza,Tanja D. de Gruijl,David E. Gyorki,Axel Hauschild,Tina J. Hieken,James Larkin,David H. Lawson,Céleste Lebbé,Jeffrey E. Lee,Michael C. Lowe,Jason J. Luke,Grant A. McArthur,David F. McDermott,Jennifer L. McQuade,Tara C. Mitchell,Teresa M. Petrella,Peter A. Prieto,Igor Puzanov,Caroline Robert,April K.S. Salama,Shaneen Sandhu,Dirk Schadendorf,Alexander N. Shoushtari,Jeffrey A. Sosman,Susan M. Swetter,Ken K. Tanabe,Samra Turajlic,Douglas S. Tyler,Scott E. Woodman,Frances C. Wright,Jonathan S. Zager,Paolo A. Ascierto,Andrew J. Spillane,Andrew J. Spillane,Andrew J. Spillane,Alexander C.J. van Akkooi,Jennifer A. Wargo,Christian U. Blank,Hussein Abdul-Hassan Tawbi,Georgina V. Long,Georgina V. Long,Georgina V. Long +97 more
TL;DR: The International Neoadjuvant Melanoma Consortium is established with experts in medical oncology, surgical oncologist, pathology, radiation oncologists, radiology, and translational research to develop recommendations for investigating neoadjuant therapy in melanoma to align future trial designs and correlative analyses.